Dr. Peter Carlen

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, has expanded its research collaboration in field of epilepsy with a new collaboration with the University of...